- advertising -

L'Oréal Groupe launches an ingredient to treat localized pigmentation disorders

Melanin levels increase after sun exposure to protect skin cells. Many factors can disrupt the normal production of this natural pigment, leading to localized pigmentation disorders such as brown spots and post-inflammatory marks. According to an epidemiological study, half the population has at least one pigmentation problem*.

Backed by 35 years of research dedicated to pigmentation, L'Oréal Groupe has presented Melasyl, a molecule designed to treat these disorders, at the American Academy of Dermatology's annual meeting, being held in San Diego from March 8 to 12, 2024. This multi-patented ingredient is the culmination of rigorous testing in over 121 scientific studies, says the group.

L'Oréal formulations containing this new patented ingredient treat pigmentation marks and are said to improve their appearance, whatever the skin phototype. Cosmetic products formulated with Melasyl are said to deliver a more even, natural-looking complexion, even on the most persistent marks. 

The fruit of 18 years' research, Melasyl is now available in La Roche-Posay's Mela B3 range, including MelaB3 serum and MelaB3 SPF30 skincare. L'Oréal Paris and Vichy will be launching other products with this ingredient.

"Half of the people surveyed reported pigmentation problems, and a third of these had a negative impact on their quality of life, proving that the impact of visible spots or post-acne marks is not just cutaneous, said Anne Colonna, International Director of Advanced Research at L'Oréal Groupe. Melasyl is a unique ingredient with proven efficacy in the treatment of localized pigmentation disorders, which, thanks to its accessibility to as many people as possible, will help people regain their self-confidence."

Melasyl was presented for the first time at the World Congress of Dermatology 2023 in Singapore, alongside the world's first epidemiological study of pigmentation disorders. 

* Epidemiological study carried out on 48,000 people in 34 countries by La Roche-Posay; selected as a major news item at the World Congress of Dermatology in Singapore on July 5, 2023.

Photo: © Engin Akyurt / Pixabay

External resources
Website

Sponsored content

site-industries-cosmetiques A smiling woman with long hair stands in an open field. The text reads: "See you at in-cosmetics global, April 8-10 in Amsterdam, stand 11J41. Discover the Holistic Beauty Study with Cerebiome® for skin health." The Lallemand logo is visible in the bottom corner.

New publication with Cerebiome® for the intestine-brain-skin axis

Lallemand Health Solutions' innovative formula shows benefits for occasional stress, sleep quality and skin appearance.
site-industries-cosmetiques A woman with long brown hair and green eyes poses pensively against a colorful background of automobile drafts. She touches her face with one hand, revealing pink lips and pale skin, while the lighting accentuates her features.

VividEYE™

Brightens dark circles and reduces puffiness.

Related articles

Our last issue

Listen to us!

Newsletter

en_USEnglish